Cramer Executive to Share Expertise, Insight at Drug Information Assoc Workshop
February 19, 2008
NORWOOD, MA, February 19, 2007 – Cramer, a digital marketing and events solutions agency, today announced that Liz Kay will be a panel participant at the Drug Information Association’s (DIA) “20th Annual Workshop Marketing of Pharmaceuticals in a Time of Change” event. The workshop is focused on key issues that the pharmaceutical advertising and promotion industry are facing today such as enforcement, off-label promotion, training, the new physician labeling rules, state regulations and the increasingly important role of the Office of Inspector General (FDA). The event is February 19-21, 2008, in New York City.
Kay is the Vice President, Account Services of Cramer’s Healthcare practice and her panel titled “Internet: WebMD/About.com – Where are Consumers going on the Internet to Gather Information?
Guidelines, Compliance and Regulations,” will be led by John F. Kamp, JD, PhD, Executive Director, Coalition for Healthcare Communication. Meg Columbia Walsh, Managing Partner, CommonHealth and Linda Ballai Fischer, Senior Director, Regulatory Affairs, King Pharmaceuticals, Inc. are co-panelists with Kay. The panel discussion will be held at 1:30 p.m. on Thursday, February 21.
“As more and more patients and physicians seek out healthcare information online, it is important for the pharmaceutical industry to take steps to better understand the behavior and needs of patients. This understanding will have a positive qualitative and quantitative impact on healthcare outcomes,” explains Liz Kay. “Currently, this is an unregulated, largely unstructured environment; it is our responsibility as an industry to create that structure, to build best practices designed to simultaneously drive a healthier community and to grow business. This DIA workshop is exactly the kind of forum in which we can all discuss these issues and learn more about how we can build on our successes to date.”
The DIA is a professional association of more than 18,000 members worldwide who are involved in the discovery, development, regulation, surveillance or marketing of pharmaceuticals or related products. The organization is committed to the broad dissemination of information among its members, with continuously improved professional practice as the goal. DIA serves its members in a neutral, global environment that operates independently of the influence of any one organization or authority.
Since the launch of Cramer’s Healthcare practice in October 2006, the agency’s client portfolio has grown exponentially. The Healthcare practice currently serves more than 15 major clients in the pharmaceutical, biotechnology, diagnostic and medical device industries. Cramer Healthcare has produced award-winning work for Bayer Healthcare’s diagnostic division and played an integral role in the development and success of EMD Serono’s Fertility LifeLines and MSLifeLines support programs.
About Cramer
Cramer is a digital marketing and event solutions agency that fuses creativity and technology to design and execute experiences that move audiences. For more than 25 years, the agency has helped the world's leading and emerging brands win and retain loyal customers, launch products and inspire sales teams. Reaching audiences online, offline, through emerging media, and face-to-face, Cramer creates personalized, integrated marketing programs and events that maximize marketing impact – and their clients' dollars. Cramer’s clients include MasterCard, Boston Scientific, Business Objects, Gillette and EMD Serono, Inc. Cramer is a privately-held company. For more information please go to http://www.crameronline.com or visit their blog at http://www.awidernet.com.
Contact
Rebecca Hodgkins
781-278-2460
rhodgkins@crameronline.com